RALEIGH, N.C.--(BUSINESS WIRE)--Gemelli Biotech and its technologies will be featured in several presentations at Digestive Disease Week® (DDW) 2025. These studies used Trio-Smart®, a diagnostic 3-gas ...
Gemelli Biotech's Trio-Smart® 3-Gas Breath Test and IBS-Smart® Blood Test, Featured Across Multiple Research Presentations at DDW 2026 Studies utilizing Gemelli’s proprietary diagnostic technologies ...
Many of these findings were determined using the proprietary breath testing instruments and state-of-the-art collection kits developed and distributed by Gemelli Biotech using the only three-gas, mail ...
Studies utilizing Gemelli’s proprietary diagnostic technologies demonstrate key clinical applications, advancements in IBS and SIBO diagnostics, and treatment support. These findings will be presented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results